Incyte Corporation

Total Valuation

Incyte Corporation carries a market capitalization of 24.62B, placing it among publicly traded companies globally. Its enterprise value stands at 18.29B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

Incyte Corporation currently has 200.98M shares outstanding.

Valuation Ratios

Incyte Corporation trades at a trailing price-to-earnings ratio of 13.94. The price-to-sales ratio is 3.86, and the price-to-book ratio stands at 3.59.

Enterprise Valuation

On an enterprise value basis, Incyte Corporation trades at an EV/EBITDA multiple of 9.43 and an EV/FCF ratio of 9.09. The EV/Sales ratio of 3.14 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 9.94 provides insight into valuation relative to core operating earnings.

Financial Position

Incyte Corporation maintains a current ratio of 4.59, meaning it holds 4.6x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.60, indicating moderate leverage, while an interest coverage ratio of 833.59 demonstrates strong ability to service its debt obligations.

Financial Efficiency

Incyte Corporation posts a return on equity of 30.67 and a return on invested capital of 28.44.

Taxes

Over the trailing twelve months, Incyte Corporation has paid 354.98M in income taxes, reflecting an effective tax rate of 18.04.

Stock Price Statistics

Incyte Corporation's stock has gained approximately 46.10296% over the past 52 weeks. The 50-day moving average sits at 121.60, while the 200-day moving average is 105.15.

Income Statement

Over the trailing twelve months, Incyte Corporation generated 5.82B in revenue and converted that into 1.61B in net income, yielding earnings per share of 7.85. EBITDA reached 1.94B, while operating income came in at 1.84B.

Balance Sheet

Incyte Corporation holds 4.54B in cash and equivalents against 38.27M in total debt, resulting in a net debt position of -3.98B. Total book value stands at 6.34B, with working capital of 4.71B providing operational flexibility.

Cash Flow

Incyte Corporation produced 1.98B in operating cash flow over the past twelve months. After subtracting -30.00M in capital expenditures, free cash flow totaled 1.95B - equivalent to 9.84 per share.

Margins

Incyte Corporation operates with a gross margin of 92.62, reflecting its pricing power and cost economics. The operating margin of 31.61 and net profit margin of 27.71 provide insight into operational efficiency.

Dividends & Yields

Stock Splits

Incyte Corporation's most recent stock split took place on September 1, 2000 with a 1:2 split ratio.

Scores

Incyte Corporation posts an Altman Z-Score of 11.44, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.